The new credit facility provides USPH with increased financial flexibility and a longer maturity profile, which supports its growth strategy and shareholder return initiatives. Traders should monitor the company's use of the facility for potential acquisitions and share repurchases.
Price Chart
Executive Summary
U.S. Physical Therapy, Inc. (USPH) entered into a $450 million credit facility, consisting of a $175 million term loan and a $275 million revolving credit facility, replacing its previous $325 million facility. The new facility extends the maturity to 2031, provides increased borrowing capacity, and will be used to refinance existing debt, fund future acquisitions, and support general corporate purposes including shareholder returns.
Key Financial Metrics
Key Facts
- Entered into a $450 million credit facility with a maturity date of April 14, 2031.
- The facility consists of a $175 million term loan and a $275 million revolving credit facility.
- The new facility replaces the previous $325 million credit facility.
- Proceeds will be used to refinance existing debt, fund future acquisitions, and support general corporate purposes.
- The company's CEO stated the new facility reflects strong credit profile and confidence from banking partners.
Financial Impact
The new $450 million credit facility provides $125 million in additional borrowing capacity compared to the previous $325 million facility.
Risk Factors
- Increased leverage from the new facility could impact financial ratios.
- The company's ability to generate sufficient cash flow to service the new debt.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000885978-26-000017 |
| Exhibit: ex99-1.htm | 0000885978-26-000017 |
| Document: form8-k.htm | 0000885978-26-000017 |
| Document: 0000885978-26-000017-index-headers.html | 0000885978-26-000017 |
| Document: 0000885978-26-000017-index.html | 0000885978-26-000017 |
| Document: 0000885978-26-000017.txt | 0000885978-26-000017 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | SC 13G | $85.44 $87.02 | ▲ +1.85% | ▲ +3.00% | $87.47 (+2.38%) |
Aug 10, 2026 11w ago | 8-K | $81.67 $78.21 | ▼ −4.24% | ▼ −3.83% | $87.47 (+7.10%) |
May 6, 2026 24w ago | 8-K | $59.00 $60.14 | ▼ −1.93% | ▼ −0.43% | $87.47 (−48.25%) |
Apr 15, 2026 27w ago | 8-K | $78.18 $74.76 | ▼ −4.37% | ▼ −5.36% | $87.47 (+11.88%) |
Feb 26, 2026 34w ago | 8-K | $78.87 $82.14 | ▲ +4.15% | ▲ +5.27% | $87.47 (+10.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers